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Abstract
Influenza viral particles are enveloped by a lipid bilayer. A major step in infection is fusion of the viral
and host cellular membranes, a process with large kinetic barriers. Influenza membrane fusion is
catalyzed by hemagglutinin (HA), a class I viral fusion protein activated by low pH. The exact nature
of the HA conformational changes that deliver the energy required for fusion remains poorly
understood. This review summarizes our current knowledge of HA structure and dynamics, describes
recent single‐particle experiments and modeling studies, and discusses their role in understanding
how multiple HAs mediate fusion. These approaches provide a mechanistic picture in which HAs
independently and stochastically insert into the target membrane, forming a cluster of HAs that is
collectively able to overcome the barrier to membrane fusion. The new experimental and modeling
approaches described in this review hold promise for a more complete understanding of other viral
fusion systems and the protein systems responsible for cellular fusion.
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1. Introduction
Membrane fusion is a key step in many biological processes. Processes such as intracellular
compartmentalization and trafficking, neuronal signaling, entry of enveloped viruses, exocytosis,
muscle repair, and cell‐to‐cell fusion in development all depend on enzymes that catalyze the
merging of two lipid bilayers [1‐8]. In cellular infection by enveloped viruses, membrane fusion
represents the final step before the viral genome is released into the cytosol of the target cell. The
key molecular step underlying fusion involves viral proteins that insert hydrophobic sequences into
the target membrane and refold to drive merging of the lipid bilayers. So far, three major classes of
viral fusion proteins have been characterized [4,5]. The first class comprises the fusion proteins of
viruses such as HIV‐1, ebola, and influenza. Class I fusion proteins are trimeric proteins with central
coiled coil motifs as the key structural scaffold that enables the conformational changes needed for
fusion. Class II fusion proteins, found in viruses such as dengue, zika and chikungunya, generally
possess extended beta‐sheet structures and rearrange from a dimeric geometry in the prefusion
state into a trimer in the postfusion form. Class I and II proteins need to undergo a proteolytic
priming and triggering event. Class III fusion proteins, for example from vesicular stomatitis virus and
herpes simplex virus, show combinations of these structural motifs and lack a major priming event.
The reovirus small proteins that induce cell‐cell, but not virus‐cell fusion have been proposed to
represent a fourth class of viral fusogens [8,9].
One could consider viruses as evolutionarily optimized nanodevices, primed to enter and take over a
host to ensure their continued existence [10]. The different viral fusion systems encountered in
nature each represent elegant solutions to a biophysically challenging problem: the catalysis of the
kinetically highly unfavorable merging of two bilayers. This review will discuss our current knowledge
of the mechanistic operating principles of the influenza fusion machinery, arguably the most
intensively studied viral fusion system. In particular, we will observe the problem through a
biophysical lens; we will review structural knowledge on the influenza fusion system and discuss
recent approaches relying on molecular modeling and single‐particle microscopy that describe the
fusion process. These biophysical studies suggest an intricate orchestration of the activity of a large
number of fusion proteins as a key requirement for membrane fusion, suggesting that full
understanding of viral fusion will need to come from both a detailed knowledge of the structural and
chemical properties of the fusion proteins and a more holistic treatment of the interactions between
larger numbers of fusion proteins connecting the viral and target membrane.
Influenza virus is a canonical example of an enveloped virus that has caused world‐wide pandemics
[11]. Because it inhabits multiple hosts and readily mutates, the threat of a new pandemic is real.
The fusion of the viral and host cell membranes is mediated by hemagglutinin, a class I trimeric
fusion protein. Viral entry is initiated by the virus binding to host‐cell receptors via an interaction
with a subdomain of the hemagglutinin and followed by cellular uptake into an endosomal
compartment [12]. The low‐pH environment of the matured endosome initiates a conformational
change in the hemagglutinin structure causing it to extend and insert a hydrophobic N‐terminal
peptide into the target membrane. A subsequent refolding of the protein results in the two
membranes to be pulled together and fuse.

Membrane fusion generally is not a spontaneous process on a biological timescale: the merger of
two lipid membranes is thermodynamically favorable but has several kinetic barriers [13]. The
essential characteristic of a biological membrane is the combination of a polar, hydrophilic exterior
formed by the lipid headgroups and an apolar, hydrophobic interior containing the lipid tails [14].
Major players in membrane arrangement are the hydrophobic effect, giving rise to a poorly
understood but strong interaction, polar and polarizing (Van der Waals) forces, and the interaction
with water (hydration force) [15,16]. The interplay between these forces and the geometries of the
system, such as lipid shape and membrane curvature, are key to the energetics of the membrane
fusion process.
After being brought into close proximity, both the viral and target membranes have to be stripped of
the hydration layer, the water layer that is tightly interacting with the polar headgroups of the lipids.
Fusion of the two membranes then proceeds through a hemifusion stalk, an intermediate in which
the proximal leaflets have merged. The final steps of fusion are the opening of a pore, so that
aqueous contents on both sides of the membrane are connected, and subsequent expansion of the
pore [13,17,18]. The progression from two separate membranes into a single contiguous one may be
supported by lowering of the transition barriers, i.e. through the interaction with a catalyst or
enzyme, or by the input of additional free energy through work [17,18].
This review aims to highlight the recent insights into the action of the influenza hemagglutinin as a
catalyst and workhorse of this intricate membrane fusion process, and the role played by the kinetic
steps and spatial distribution of HA as elucidated by single‐particle studies. We will first discuss our
current knowledge of the structural states and conformational dynamics of HA acquired from
structural, computational and biochemical studies. As a central component of this review, we will
then provide a description of single‐particle methodologies and the insight they have given us, and
discuss how collaboration of multiple hemagglutinins overcomes the membrane fusion barrier.

2. Hemagglutinin structure and conformational
rearrangement
2.1 Hemagglutinin‐mediated membrane fusion
The influenza A hemagglutinin (HA) is intensively studied and has since long served as a model
system for viral fusion proteins [19]. The HA glycoprotein is synthesized as an inactive precursor,
designated HA0 [20]. Cleavage in the trans‐Golgi network by a host‐cell protease results in a
metastable, disulfide‐bonded complex of HA1 and HA2 [21,22]. The crystallization of both the
prefusion [23] and postfusion [24,25] structures of HA2 has brought tremendous insight into the
large conformational changes involved in the fusion process. Biochemical and computational work
has helped to fill in many details, including the role of HA1, the fusion peptide and possible
intermediate states.

The global rearrangements of the trimeric HA1/HA2 complex and their hypothesized relations to the
different steps of membrane fusion are depicted in Figure 1. The virus particle engages the target
membrane with receptor attachment mediated by HA1 (A), which in later steps gives way for HA2 to
extend (B). Upon lowering of the pH, the hydrophobic N‐terminal end of the hemagglutinin is
liberated from a pocket in which it was sequestered (B). This fusion peptide inserts into the target
membrane, driven by the formation of an extended coiled‐coil structure bridging the two
membranes (C). The globule (yellow in Figure 1) at the base of HA melts and subsequently zippers up
along the formed coiled coil, fusing the outer leaflets of the two membranes (hemifusion) (D). A
pore is formed (E) when fusion peptide and transmembrane domain come together and the distal
leaflets merge. Expansion of the pore then allows the viral genome to enter the cell.

2.2 HA structural rearrangements
The crystallographic structure of HA at neutral pH, shown in Figure 2A, reveals that HA1 forms a
globular head in a region that is distal from the viral membrane. This part of the protein bears the
receptor‐binding domain (shown as a green hash) and is located 135 Å from the viral membrane
[26]. Both the C‐ and N‐terminal ends of HA1 extend towards the viral membrane, where they form
a hydrophobic pocket for the fusion peptide (red in Figure 2). A disulfide bond near the N terminus
of HA1 connects it to HA2 (black star in Figure 2A2). The core of the protein complex is formed by an
80 Å‐long triple‐stranded coiled coil of alpha helices from each of the three HA2 subunits. A globular
domain at the bottom of this coiled coil forms the base of the protein (yellow in Figure 2A) and is
connected to the three transmembrane helices that anchor the HA in the viral membrane. From the
top of the coiled coil an unstructured loop (B‐loop, blue in Figure 2A) doubles back towards the viral
membrane, terminating in the fusion peptide. The sequence of the fusion peptide is highly
conserved amongst different virus strains [27] and plays an important role in both triggering the
conformational change [28] and manipulating the target membrane (reviewed in [29] and [30]).
In the low‐pH, postfusion structure (Figure 2E), the B‐loop has undergone a loop‐to‐helix transition
and extends the central coiled coil (blue), together with the alpha helix that was already present in
the prefusion state (grey helices). The helical stretch originally at the bottom of the central coiled
coil (purple) has partly undergone a helix‐to‐loop transition, forming the turn in the postfusion
hairpin structure. To facilitate this transition, the small globular bottom of HA2 (yellow in Figure 2A)
is required to (partially) unfold while breaking the threefold symmetry of the trimer. This domain
then packs into the grooves between the helices that form the core of the postfusion conformation
(visible as yellow in Figure 2E1). For the related Influenza B virus, similar structural rearrangements
have been found [32]. The Influenza C virus hemagglutinin esterase in addition functions as the
receptor‐cleaving enzyme [33].

2.3 HA intermediate conformational stages
While the structures of the prefusion and postfusion states of HA are known, the exact nature of the
conformational transition between these two states is poorly understood. In the prefusion structure,
HA2 is held in a metastable state by the surrounding subunit HA1 and the tight binding of the fusion

peptide. Destabilization of HA at a pH between 5 and 6 [34,35] or at elevated temperatures [36]
induces the release of the fusion peptides from their pockets and dissociation of the ‘clamp’ formed
by the HA1 globular domains, enabling a cascade of refolding events. The resulting release of energy
is used to pull the membranes together for fusion [37].

2.3.1 Fusion peptide release mechanism
The release of the fusion peptides upon pH drop precedes the dissociation of HA1, as shown by
antibody binding [38] and hydrogen‐deuterium exchange experiments [39], and seems to be a
reversible step [40,41]. This release is caused by protonation of specific residues in and around the
peptide and its binding pocket [28]. Among others, His17 in HA1 and Asp109 and Asp112 in HA2
have been shown to influence the pH sensitivity, using mutants of HA that fuse at an elevated pH
relative to the wild type [42‐44]. However, protonation of one residue influences the protonation
equilibrium of neighboring residues, which complicates the identification of single critical residues
and makes it more likely that multiple residues can contribute to the destabilization of this region
[44‐46].

2.3.2 HA1 dissociation mechanism
Dissociation of HA1 is a necessary step for fusion, as shown by a chemical cross‐linking of the
globular domains inhibiting the fusogenic conformational changes and abolishing membrane fusion.
[47‐49]. At low pH, the HA1 subunits retain their structure and the ability to bind the sialic‐acid cell
receptor [50,51]. Key molecular switches that interrupt the association between the HA1 subunits
have not been unambiguously determined. Fusion assays on HA mutants have revealed several salt
bridges and hydrogen bonds at the subunit interfaces that are weakened upon protonation of one of
the participating residues [28]. Among these are the highly conserved His184 at the HA1‐HA1
interface [52] and His205 in a pandemic 2009 H1N1 strain [53]. Both the loss of specific stabilizing
contacts and an increased net charge on the subunits could contribute to the dissociation of HA1
[46].

2.3.3 The extended intermediate
Before crystallization of the postfusion structure, the existence of the loop‐to‐helix transition had
already been predicted by the discovery of a strong tendency for coiled coil formation in the initially
unstructured B‐loop [22]. The energy stored in this part of the prefusion trimer is released after
removal of the clamp formed by the fusion peptide and HA1, inducing a ‘spring‐loaded’
conformational change towards the state with lower energy [54]. Additionally, the fusion peptide,
connected to the B‐loop, has been shown to insert into the target membrane before fusion [55,56].
Together, these observations lead to the hypothesis of an extended intermediate that establishes
the connection between the two membranes [22]. Indirect evidence for the existence of such an
intermediate in fusion mediated by class I proteins stems mainly from the development of peptides
that inhibit HIV entry by binding to an extended intermediate of the HIV fusion protein gp41 [57],
especially when these peptides are anchored to the target membrane [58]. Time‐of‐addition

experiments with the peptides indicate that the gp41 extended intermediate exists for at least a few
minutes [59]. Similar inhibitory peptides indicate the existence of the intermediate during refolding
of influenza HA, although much higher peptide concentrations as well as cholesterol conjugation are
needed for effective inhibition of influenza fusion [60]. Based on the average lag time between virion
arrest and subsequent hemifusion, the lifetime of the extended intermediate of HA could be as
much as one minute [61].

2.3.4 Refolding for hemifusion
The energy required to bring the membranes together is delivered by the unfolding of the globular
bottom of HA2 and its packing into the groove between the helices of the extended intermediate
(yellow in Figure 2) [62]. This leash‐in‐a‐groove mechanism is inhibited by peptides derived from the
amino‐acid sequence in the leash, presumably by occupying the groove before HA refolding is
complete [60]. Additionally, mutation of hydrophobic residues at the end of the leash decrease the
efficiency of hemifusion. Further, additional residues beyond the leash, contacting the residues that
cap the N‐terminal end of the coiled coil, are likely to add a significant amount of energy by
stabilizing the postfusion conformation [25]. It is still unclear whether the tight packing of these
residues is necessary only for pore formation [63] or also for hemifusion [62]. If the fusion peptides
fail to insert into the target membrane before hairpin formation, the HA protein can refold
unproductively and end up in an inactivated state. This inactivation is demonstrated by an
irreversible loss of fusion activity after pretreatment of the protein with low pH [64]. Moreover, in
the absence of target membrane, the fusion peptides insert into the viral membrane, completing
inactivation [65,66].

2.4 Membrane sculpting and pore formation
The HA transmembrane domains and fusion peptides play an active role in the fusion process rather
than just providing a passive mechanical connection between the viral and the target membrane.
For example, certain single amino‐acid substitutions in the fusion peptide abolish fusion, while not
hampering HA expression or conformational changes (reviewed in [30]). On the membrane surface,
the 23 amino‐acid fusion peptide forms a helical hairpin structure [67,68] with an inverted wedge
shape that induces negative curvature in the membrane [69]. This membrane deformation is
thought to have a stabilizing effect on the hemifusion stalk with its strong negative curvature. In
addition to the active role of the fusion peptides, it has been shown that part of the transmembrane
domain is necessary for pore formation and enlargement, but not for hemifusion [70‐73]. The
association of the fusion peptides with the transmembrane domain [25] is also implicated in
membrane remodeling through an increase in membrane perturbation [74‐76]. Hence, interactions
between the fusion peptides, transmembrane domains and the lipid bilayers can lower the barriers
involved in membrane fusion.

3. Collaboration between hemagglutinins as unraveled
by single‐particle experiments
3.1 Single‐particle approaches to study influenza viral fusion
3.1.1 Kinetic studies of influenza viral fusion
The first methods to study the kinetics of fusion were developed in the 80s, with assays employing
viruses fusing to liposomes in solution [77,78], viruses fusing to cells [79] and HA‐mediated cell‐cell
fusion [80]. These and later studies revealed significant new mechanistic information. It was shown
that fusion initiates by a pH‐dependent step of HA2 [81]. The rates of HA inactivation and HA‐
mediated fusion were found to be correlated [82], and particle docking via receptor binding
influenced the fusion rate [83]. The fusion rate correlates with the density of HAs expressed on cell
surfaces [84‐87], suggesting that fusion involves a step that relies on the participation of more than
one HA trimer. However, whether this necessarily involves inter‐HA interactions is hard to conclude
from these types of experiments. A large number of studies have established that multiple HAs are
needed for fusion, yet there is no consensus on the number of HAs involved [88‐93]. The number
found depends on the experimental technique used and the model applied. The inherent limitation
of bulk fusion studies is the observation of only ensemble averages, obfuscating differences within
the population that are likely to arise from stochastic molecular events. Furthermore, the advantage
of using intact virions instead of HA‐expressing cells is that HA is studied in the native context of a
whole virus particle, and enables the extension of the system under study to include fusion
inhibitors. Finally, the use of fast and synchronous triggering of the virus population has been
difficult for bulk assays and observing with high data acquisition rates is paramount to resolving
distributions within populations and short‐lived intermediate states.

3.1.2 Single‐particle assays provide access to hidden intermediates
In recent years, new experimental tools have been developed that enable the visualization of fusion
events at the level of single viral particles. By monitoring distributions of properties of individual
particles within a population rather than an ensemble average, information can be inferred about
subpopulations. Furthermore, observation of the fusion process at the single‐particle level allows for
the visualization of short‐lived states that otherwise would be averaged out due to the
asynchronicity of the different kinetic transitions. The reader is referred to [94] for a review on
single‐particle methods to study fusion and to [95] for an overview of the various kinetic approaches
to the study of influenza fusion in particular, both at the ensemble and single‐particle level. Here, we
will focus on new insights obtained by single‐particle methods into the collaborative action of HA
proteins on the surface of an influenza particle to mediate membrane fusion.

3.1.3 Experimental design of single‐particle viral fusion assays
The main features and outcomes of a typical single‐particle fusion assay are shown in Figure 3. The
membrane and the aqueous interior of the virus particle are fluorescently labeled and shown in
green and red, respectively, and their fluorescence is imaged using total internal reflection
fluorescence microscopy (TIRF‐M), a technique that allows the selective laser excitation of a very
thin volume near the coverslip surface (Figure 3B). A planar target bilayer of controlled lipid
composition is formed on a glass support and can be designed to incorporate lipid or proteinaceous
receptors and a lipid‐coupled pH‐sensitive fluorescent probe. Synchronous acidification is achieved
in a microfluidic channel by flowing in low‐pH buffer [96], by light‐induced liberation of caged
protons [97] or by pre‐mixing [98]. Using TIRF‐M, low‐background and high‐contrast fluorescence
signals are extracted to monitor particles rolling along the bilayer and to visualize arrest, hemifusion
and opening of a pore (Figure 3A). The high concentration of dye in the viral membrane causes self‐
quenching of its fluorescence, allowing hemifusion to be detected as a dequenching and sudden
increase in fluorescence when the dye escapes into the target membrane through the hemifusion
stalk, followed by dissipation of the signal as the dye diffuses outwards into the supported bilayer
(Figure 3C). Depending on the virion labeling procedure, the inner leaflet may hold dye that cannot
escape, so abortive hemifusion events are not discriminated from successful ones. Disappearance of
the content signal reports on the formation of a pore as the dye inside the particle escapes
underneath the supported membrane (Figure 3D). Partway dissipation of the content dye shows
either closure of the pore, or the presence of more than one particle in the spot. The times for
individual particles to arrest, to hemifuse and to form a pore are collected and plotted in histograms
such as the one shown in Figure 3E, F and G. Hence, by observing large numbers of single particles,
the distribution of the population of fusing particles is observed, rather than an average of the whole
population. These distributions allow us to draw conclusions about the molecular mechanisms
underlying the fusogenic activity of HA (as discussed in more detail below).

3.2 Mechanistic insight into HA activity from single‐particle
experiments
3.2.1 Kinetic insight from single‐particle histograms
In single‐particle assays, the main experimental readout is the distribution of times that individual
particles take to reach a certain state (arrest, hemifusion or pore formation), as seen in Figure 3. The
shapes of these distributions contain information about the number of rate‐limiting kinetic
transitions needed to reach the observable state [99]. A process that requires only a single rate‐
limiting step results in a distribution that can be described by an exponential decay function, with
the decay constant equal to the rate constant of the single rate‐limiting transition (Figure 4A). In the
case of multiple, different steps that need to be taken in sequence, a delay is introduced: each step
has to wait for the previous to complete. The latter scenario results in a so‐called rise‐and‐decay
distribution that, in contrast to a single‐exponential distribution, has a rise and fall in the number of
events over time. Importantly, when a final state can only be achieved by a number of identical
processes that take place in parallel, a similar rise and decay is observed as in the sequential case
(Figure 4B). After all, the system arrives in the final state not until all required parallel transitions
have completed.

Single‐particle experiments on influenza viral fusion showed that the waiting times between
decrease of the pH and the cessation of rolling, and hemifusion and pore formation events showed
rise‐and‐decay behavior, suggesting that these processes involve multiple steps [61,88,96,97,100].
The powerful combination of single‐particle experiments and analytical [101] and numerical [61]
modeling has resulted in a picture in which fusion is the result of a number of HAs acting in a
parallel, stochastic fashion, whose proximity allows their stochastic activity to result in a level of
coordination needed to overcome the large energetic barriers associated with fusion. In the
remainder of this review, we will analyze in more detail the evidence for such a stochastic view of
cooperativity.

3.2.2 Particle rolling and arrest as a proxy for HA fusion peptide insertion
Single‐particle fusion experiments on influenza with the pH drop performed in the presence of a
laminar flow, showed rolling of the particles along the planar target membrane for some time after
acidification [61]. The distribution of times for the particles to stop rolling after acidification showed
a rise‐and‐decay behavior (Figure 3E). The way in which this behavior is interpreted and modeled is
shown in Figure 4. The section of the virus in contact with the target membrane, the contact patch
(Figure 4C, D), is modelled on a hexagonal grid (Figure 4E). With the dense packing of HA on a virion,
the number of HAs typically in a contact patch is estimated to be 50–150 [61]. For visualization
purposes, a patch of only 19 HAs is shown. Upon acidification, each HA trimer in the contact patch
activates at a rate described by a single rate constant, determined by the rate‐limiting step in the
conformational transitions leading to extension and insertion of the fusion peptide into the target
membrane. When a critical number of HAs have formed a bridge between the viral and target
membranes, the particle is arrested. This situation corresponds to the process depicted in Figure 4B:
a critical number of HAs need to have extended and inserted their fusion peptides before the
particle is halted. When the individual insertion times are exponentially distributed, the total time
for a number of these reactions to be completed will be represented by a convolution of single‐
exponential distributions and will have a rise‐and‐decay shape (Figure 4B). Using the combination of
single‐particle experiments and modeling, the typical number of insertions required for arrest was
found to be three [61,101].

3.2.3 Insertion of the fusion peptide as a single‐barrier transition
A framework to model protein conformational changes with a kinetic barrier was previously
developed and successfully applied to single‐molecule pulling experiments [102]. This model was
also applied to HA membrane insertion, using a rate constant that is a function of pH [101]. As noted
in Section 2, the influenza HA undergoes a proteolytic priming step that renders its prefusion
structure metastable: the postfusion, conformationally rearranged protein has a lower free energy
of folding [33]. At neutral pH, the barrier for the HA to traverse to this lower‐energy postfusion
structure is too high to overcome by thermal fluctuations alone. The rate of HA rearrangement was
inferred to be pH dependent [39,103]. Experiments performed at elevated temperature show that
fusion can also proceed at physiological pH [36], indicating that there is a kinetic barrier for the HA
to undergo the conformational rearrangement. Figure 4A (left) shows the resulting model: the

barrier for the HA to extend and insert its fusion peptide into the target membrane is lowered with
decreasing pH, and the resulting transition rate is pH dependent. For certain strains, this rate‐
limiting step was found to correspond to the expulsion of the fusion peptide from the pocket in
which it was sequestered [61]. Hence, the probability of insertion of a single HA trimer is modeled as
a single‐exponential decay (Figure 4A right).

3.2.4 Hemifusion is mediated by a cluster of independent HA insertions
The distribution of the hemifusion times (Figure 3F) also shows that there are multiple steps
involved in forming this intermediate. It has been found that the barrier to membrane fusion is too
large to be overcome by a single HA and that 2 to 6 trimers need to participate together as a
fusogenic unit. For influenza, it has been proposed that multiple HA trimers act together in a small
area and that the formation of a critical cluster of neighboring inserted HAs drives fusion (Figure 4E
rightmost) [89]. Other viruses similarly require the involvement of multiple copies of the fusion
protein [4,104‐106].
The collaboration of multiple HAs is modeled as follows. After the insertion of a critical number of
HAs into the target membrane has firmly docked and immobilized the viral particle, visualized by the
arrest of rolling, HAs continue to insert into the target lipid bilayer. With the HA trimers transitioning
to the collapsed postfusion state, the two membranes will be pulled closer together at points where
a trimer has successfully inserted its fusion peptides. When a group of HA trimers close enough in
space and time (Figure 4E rightmost, example of 3 shown) convert to the collapsed conformation,
the fusion barrier that is too large for a single HA can be overcome. Once such a cluster is formed,
the collaborative refolding appears to proceed rapidly [61]. The rise and decay that is measured for
hemifusion hence arises from the multiple steps involved, and has a different shape than the arrest
distribution because of the geometrical requirement (Figure 4 right). Single‐particle estimates for the
cluster size vary somewhat between influenza strains, but lie around 2 to 3 [100,101].

3.2.5 Pore formation and pore expansion: multiple players
Pore formation is measured as a disappearance of the content dye signal from the particle. Figure
3G shows a typical experimentally determined distribution of times to pore formation. A particle‐by‐
particle analysis of the times elapsed between hemifusion and pore formation reveals a single‐
exponential distribution and thus shows that the pore‐formation step involves a single rate‐limiting
step. It is weakly pH dependent, but remains a one‐step transition over the pH range probed [96].
The presence of a single rate‐limiting step seems to suggest a mechanism that is not dominated by
the stochastic action of individual HAs, as was observed for arrest and hemifusion. However, studies
using HA expressing cells indicate that there is still involvement of the HAs [107] and the fusion
peptide [108] in this step. Pressure from an expanding interior coat of matrix proteins has also been
proposed to drive pore opening in a pH‐dependent manner [109]. Moreover, the influence of
properties of the membrane is still unclear. It is apparent that there is an intricate interplay of
multiple factors driving pore opening and pore enlargement, the latter being the energetically most
challenging step in the fusion process [13].

3.2.6 Hemifusion is abrogated at sub‐stoichiometric levels of bound fusion
inhibitor
The fusion step in the viral life cycle is a key target in the search for broad‐spectrum antivirals, since
the fusion mechanism is conserved across different strains or even across different viruses. Such
drugs potentially provide longer‐lasting efficacy than drugs targeting virus attachment or release
(neuraminidase inhibitors), steps that are associated with pathways subject to much larger genetic
variation [110‐112]. Drugs targeting the conserved HA stem or extended intermediate seem
particularly promising in finding a universal influenza therapy. A single‐particle assay using
antibodies and antibody fragments that bind the stem of the HA trimer in the prefusion state and
prevent the low‐pH conformational change showed the effect of inhibiting fusion‐competent HAs
one by one [113]. By counting the number of antibodies bound per individual virion and observing
the resulting fusion yield, it was found that not all HA trimers need to be inhibitor‐bound to fully
abrogate fusogenicity, supporting the idea that hemifusion requires a network of HAs that can form
a cluster (Figure 4B left). A virus particle decorated with a large number of inhibitors will take a
longer time to achieve hemifusion, since it is less probable to form a cluster in the contact patch.
When the number of inhibited HAs is sufficiently large to prevent the formation of a fusogenic
cluster, the particle will fail to achieve hemifusion altogether (Figure 4G right and H rightmost). The
presence of such time delay and concomitant reduction in fusion yield at intermediate inhibition
levels was experimentally demonstrated [113].

3.2.7 The role of unproductive HAs
The modeling described above assumes a homogeneous coverage of fusogenic HAs on the viral
particle. However, there are several reasons that such assumption is not correct. For instance, other
proteins (neuraminidase, the M2 proton channel) may occupy space in the viral envelope otherwise
taken by HA. Moreover, some HA trimers might fail to insert into the target membrane and
inactivate. We will refer collectively to these as “unproductive” HAs. A parameter that sets the
fraction of unproductive HAs in the population can be added to the model described above. In order
to be able to quantitatively explain the inhibition levels measured in [113], a model including such
unproductive HAs predicts that a large fraction of the HAs inherently is unproductive [114]. There
are two major caveats, the first of which is that the contact patch size has not been experimentally
measured making the relationship between experimental fusion data and modeling efforts
somewhat uncertain [101,114]. Secondly, it is unknown whether all three epitopes on an HA trimer
need to be inhibitor bound to render it nonfusogenic, or that one or two suffice. However, it seems
clear that unproductive HA refolding occurs and that there might be evolutionary pressures that
balance the efficiency of individual HA insertion with the ability to transition rapidly.

3.3 Open questions and future experiments
HA activation was found to correlate with the surface density of HA [84‐87], consistent with the
presence of interactions between trimers that facilitate fusion. Such inter‐trimer interactions have
been proposed, as well as the formation of a fusogenic ring of HAs. Nevertheless, single‐particle

experiments show that such hypothesized inter‐trimer interactions are not necessary to explain
hemifusion kinetics. Instead, as argued above, a model of stochastically firing HAs suffices to explain
all reported kinetics. It remains unclear, however, whether HA assembly into a cluster is rate‐limited
by the diffusion of the HAs in the membrane, given the low surface density of HA in cell‐based
assays. Also, HA activation is reduced in the absence of a target membrane [114‐117], and there are
reversible conformational changes in the activation pathway [39‐41]. These are all phenomena that
are not incorporated into the stochastic models due to the lack of single‐particle evidence. Likewise,
the treatment of the HA conformational transition as a single activation barrier, and hence as a
single‐rate transition, is likely to need amendment once more detailed data regarding this transition
become available, for example from strains exhibiting a high pH threshold. Furthermore, whether HA
can unproductively refold after successful target membrane insertion is still unknown.
There is evolutionary pressure that balances the number of trimers required for fusion, the rate at
which the trimers activate, and the specific pH optimum of activation [100]. These reflect a balance
between transmission stability in acidic environments, which contributes to potency to cause
pandemics [118], and the location of viral RNA release in the infected cell. This location can be an
early endosome, far from the nuclear target, or close to the target in a late endosome, with a higher
risk of HA degradation by enzymes [100]. Variation in preferred entry pathway has been found for
HIV‐1 as well as for influenza [100,104] and future research into the connection between these
factors may contribute to a better understanding and prevention of flu pandemics.
Summarizing, an emerging molecular view of influenza fusion is that of a tug‐of‐war that starts after
a field of HA trimers have activated stochastically. With a section of the virus in contact with the
target membrane (Figure 4A, flattened view shown in Figure 5), several HAs potentially can
collaborate in fusion. After acidification, each HA in this contact patch individually has to overcome
the barrier to extension and insertion (Figure 5A), and HAs may accumulate in different stages of
refolding, apposing both membranes (Figure 5B). Once a critical cluster of neighboring HAs has
inserted and folds back (Figure 5C), hemifusion ensues rapidly. Finally, formation and enlargement
of a pore (Figure 5D) connects the cellular and viral compartments, initiating viral replication as the
viral genome invades the cell.

4. Towards an understanding of viral and cellular fusion
Thus far, only a subset of the protein machineries mediating cellular fusion have been identified and
their mechanisms of action characterized. Nonetheless, the proteins involved seem to be related to
those of viruses (reviewed in [8]). Bearing semblance to the different classes of viral fusion proteins,
cellular fusogens have been classified into class I and II: class I containing large alpha‐helical
domains, and class II defined by beta‐sheet structures. The class II cellular fusogens share a common
ancestral gene [119], later in evolution hijacked by different viruses [120]. Class I viral fusogens
derive from retroviral genes [8]. Similarities between the mode of action of the viral fusion proteins
and their cellular counterparts suggest that the advances in the field of viral fusion may help to guide
understanding of the proteins involved in cellular and developmental fusion.

As recent work in viral fusion has demonstrated, significant advances in mechanistic understanding
of the fusion process can be made by combining structural insight with the combination of single‐
particle experiments and modeling approaches. The strength in this philosophy is that each
approach provides new hypotheses testable in the other. The ability to isolate systems in vitro, so
that an incremental understanding can be obtained as the system is gradually made more complex,
appears to be key. Atomistic and coarse‐grained molecular modeling may provide the next step in
bridging all relevant length and time scales and finally may provide a full dynamic, atomistic model
of fusion. As more and more similarities across systems are revealed and experimental approaches
become applicable to a wide range of viral and cellular fusion systems, the biophysical and
biochemical foundations will be laid for the field of ‘fusionology’.
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Figure captions
Figure 1. The influenza hemagglutinin‐mediated membrane fusion pathway. (A) The HA1 subunit
(orange) binds sialic‐acid moieties on target‐cell receptors (dark brown). (B) After acidification, the
HA1 subunits give way and the fusion peptide (red) is liberated from its sequestered position, to
insert into the target membrane (C), allowing the HA to bridge the two membranes. The HA1
subunits are not shown from panel (C) onward. Subsequently, the trimeric HA2 then zippers up
along itself, bringing both membranes in close proximity and leading to hemifusion (D) and the
opening of a full fusion pore (E). Known structures are represented in (A) and (E), others are
inferred. For clarity, only two subunits of the trimeric HA are shown.
Figure 2. Crystal structures of HA from the neutral pH prefusion state (A in Figure 1, PDB: 1HGF [31])
to the postfusion state (E in Figure 1, PDB: 1QU1 [25]) at low pH. Color coding and stage labelling as
in Figure 1. The membrane (green), fusion peptide (red) and transmembrane domain (grey) are
shown schematically, together with the linkers connecting them to the protein. (A1 and E1) Surface
representation of the HA trimer. (A2 and E2) HA2 trimer in cartoon representation. In A2, HA2 is
covered by HA1 in transparent blue, the disulfide bond linking HA1 to HA2 is indicated with a black
star and one of the receptor binding sites with a green hash. (A3 and E3) HA2 monomer cartoons.
Figure 3. Single‐particle assay features. (A) Fluorescently labeled viral particles are imaged as they
interact with a planar supported lipid bilayer, and their dynamics (rolling, arrest, hemifusion and
pore formation) are visualized. Viral membrane is labelled green, aqueous contents are red, and
hemifusion and pore formation are detected as the escape of each respectively. (B) A thin layer
(~100 nm) is imaged using total internal reflection fluorescence microscopy (TIRF‐M), selectively
exciting and detecting the weak fluorescence from individual particles that are associated with the
membrane. (C) Hemifusion is detected as an increase of green fluorescence upon lipid mixing due to
relief of dye quenching within the viral membrane. (D) Pore formation is detected as dissipation of
the red signal as the content dye can leave the particle. (E) A histogram of viral arrest times shows a
rise and decay, suggesting the presence of multiple kinetic transitions. (F) Hemifusion times also
show a rise and decay. Both rise and decays are explained in Figure 4. (G) The time from hemifusion
to forming a pore is exponentially distributed, suggesting the presence of only one rate‐limiting
transition; the black line shows a single‐exponential fit. C and D adapted from [94]; E, F and G data
from [61,96].
Figure 4. Particle arrest and hemifusion mediated by multiple HAs within a contact patch. (A) At
neutral pH, the transition of HA from prefusion (blue) to inserted (red) form is dictated by a large
energy barrier (dotted line). At low pH, the barrier is lowered (thick line) and the HAs more readily
cross the barrier with a single rate k, yielding a single‐exponential distribution for individual insertion
times (shown right). (B) HAs in the contact patch, synchronously acidified, insert stochastically and in
parallel with single‐exponential probability. The arrest distribution is then found as a rise and decay
from the convolution of multiple exponentially distributed insertions. (C) The contact patch (blue) is
defined as the region of the viral coat (grey) in contact with the target membrane (green). (D) A
network of HAs (blue) that can participate in mediating fusion fills the contact patch. (E) The network
of HAs is modeled on a regular grid. The virus particle rolls along the membrane in the flow, forming
and breaking interactions with the sialic‐acid receptor on the target membrane. After synchronous

acidification, HAs independently and stochastically extend and insert their fusion peptide into the
target membrane (red). A critical number of insertions (circles) arrests rolling of the particle.
Formation of a critical, local cluster of inserted HAs (circle) induces hemifusion. (F, G) Inhibitors
(black; for example antibodies) interfere with the network of HAs. (H) Distributions of times to arrest
(left) and hemifusion (middle) show a rise and decay because of the multiple intermediate steps
involved. For hemifusion, the shape of the distribution is a combination of the independent
insertions and the requirement to form a local custer. For virions with a certain percentage of their
HAs blocked by inhibitors, hemifusion, i.e. formation of a fusogenic cluster, is delayed, or abolished
(right). Example contact patch of 19 HAs shown; realistic estimates are 50‐150 HAs. Critical number
of insertions to arrest and cluster size for hemifusion may vary across strains; the example shown
assumes critical numbers of 3.
Figure 5. The interplay of multiple HAs to collectively overcome the barrier to membrane fusion. A
flattened artist’s impression of the viral surface (bottom layer) and parts of the target cell membrane
(top membranes) is shown to convey the three‐dimensional geometry of the process. Metastable HA
in the prefusion conformation cover the virus surface (blue bundles). (A) An extended intermediate
is formed after low‐pH triggering. (B) HA refolding brings the membranes closer together, forming
dimples in the viral and cell membranes. (C) Once a critical, minimal cluster of inserted HAs has
formed, hemifusion ensues. (D) A fusion pore is formed, connecting viral and cellular interiors to
allow transfer of the viral genome.
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